Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada.
Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada; Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON M5S 3E5, Canada.
Stem Cell Reports. 2016 May 10;6(5):679-691. doi: 10.1016/j.stemcr.2016.04.003. Epub 2016 Apr 28.
Human pluripotent stem cells (hPSCs) exist in heterogeneous micro-environments with multiple subpopulations, convoluting fate-regulation analysis. We patterned hPSCs into engineered micro-environments and screened responses to 400 small-molecule kinase inhibitors, measuring yield and purity outputs of undifferentiated, neuroectoderm, mesendoderm, and extra-embryonic populations. Enrichment analysis revealed mammalian target of rapamycin (mTOR) inhibition as a strong inducer of mesendoderm. Dose responses of mTOR inhibitors such as rapamycin synergized with Bone Morphogenetic protein 4 (BMP4) and activin A to enhance the yield and purity of BRACHYURY-expressing cells. Mechanistically, small interfering RNA knockdown of RAPTOR, a component of mTOR complex 1, phenocopied the mesendoderm-enhancing effects of rapamycin. Functional analysis during mesoderm and endoderm differentiation revealed that mTOR inhibition increased the output of hemogenic endothelial cells 3-fold, with a concomitant enhancement of blood colony-forming cells. These data demonstrate the power of our multi-lineage screening approach and identify mTOR signaling as a node in hPSC differentiation to mesendoderm and its derivatives.
人类多能干细胞(hPSCs)存在于具有多种亚群的异质微环境中,这使得对其命运调控的分析变得复杂。我们将 hPSCs 设计成工程化的微环境,并筛选对 400 种小分子激酶抑制剂的反应,测量未分化、神经外胚层、中胚层和胚胎外群体的产量和纯度输出。富集分析显示雷帕霉素靶蛋白(mTOR)抑制是中胚层的强烈诱导剂。mTOR 抑制剂(如雷帕霉素)的剂量反应与骨形态发生蛋白 4(BMP4)和激活素 A 协同作用,可提高 BRACHYURY 表达细胞的产量和纯度。在机制上,mTOR 复合物 1 的组成部分 RAPTOR 的小干扰 RNA 敲低模拟了雷帕霉素对中胚层增强的作用。中胚层和内胚层分化过程中的功能分析表明,mTOR 抑制将造血内皮细胞的产量提高了 3 倍,同时增加了血液集落形成细胞的数量。这些数据证明了我们多谱系筛选方法的强大功能,并确定 mTOR 信号作为 hPSC 向中胚层及其衍生物分化的节点。